Metrics
Affected Vendors & Products
No advisories yet.
Solution
Mirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact Mirion Medical support directly.
Workaround
No workaround given by the vendor.
Tue, 02 Dec 2025 22:15:00 +0000
| Type | Values Removed | Values Added |
|---|---|---|
| Metrics |
ssvc
|
Tue, 02 Dec 2025 21:15:00 +0000
| Type | Values Removed | Values Added |
|---|---|---|
| Description | NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection. | |
| Title | Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication | |
| Weaknesses | CWE-603 | |
| References |
| |
| Metrics |
cvssV3_1
|
Status: PUBLISHED
Assigner: icscert
Published:
Updated: 2025-12-02T21:39:30.055Z
Reserved: 2025-11-11T20:56:52.843Z
Link: CVE-2025-61940
Updated: 2025-12-02T21:39:24.460Z
Status : Received
Published: 2025-12-02T21:15:51.930
Modified: 2025-12-02T21:15:51.930
Link: CVE-2025-61940
No data.
OpenCVE Enrichment
No data.